The Global Sevoflurane (Sevoflurane Source) Market Is Expected to Surge At 3% CAGR To Reach US$ 168 Mn by the End Of 2029.
Sevoflurane (Sevoflurane Source) Market
Information
Racemic sevoflurane (1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane), developed by Maruishi in Japan and licenced to Abbott, serves as an anaesthetic for inhalation. 25 Both Abbott, which sells sevoflurane under the name Ultane, and Baxter Health Care Corporation, which manufactures the generic equivalent, are large US businesses that currently produce the drug. The sevoflurane supplied by these two pharmaceutical firms has been deemed therapeutically equivalent by the Food and Drug Administration. 44 More sevoflurane than 99.99% of the quantity that is generally accessible is present in both of these sources. Among the less significant byproducts are hexafluoroisopropanol and a result of dehydrofluorination. 29. Sevoflurane wake-up times following cardiac surgery in intensive care units are comparable to and significantly faster than those after intravenous propofol sedation. 45
Sevoflurane is produced either through the halide exchange reaction of hexafluoroisopropyloxymethyl chloride (28) using bromine trifluoride or KF (Baxter) or by fluoroalkylation of hexafluoroisopropyl alcohol using formaldehyde and HF in the presence of fuming sulfuric acid (Abbott's method) (Figure 15). 44 Hexafluoroisopropanol is used to create compound 28 in two stages that involve O-alkylation and free radical chlorination. Sevoflurane can also be prepared using a number of alternative methods. 25
What is our Sevoflurane (Sevoflurane Source) Market Scope?
|
Report Attributes
|
Report Details
|
|
Forecast Period 2023 to 2030 CAGR
|
CAGR of 3% during the review period (2023 to 2030).
|
|
By Type
|
- Original Drugs
- Generic Drugs
|
|
By Application
|
|
|
By Companies
|
- Abbott(AbbVie)
- Baxter
- Maruishi Pharmaceutical
- Jiangsu Hengrui
- Lunan
|
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
|
Base Year
|
2021
|
|
Historical Year
|
2016-2021
|
|
Forecast Year
|
2023-2030
|
|
Number of Pages
|
104
|
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Frequently Asked Questions
What is the study period of this market?
The Sevoflurane (Sevoflurane Source) Market is studied from 2017-2022
What is the growth rate of the Sevoflurane (Sevoflurane Source) Market?
The Sevoflurane (Sevoflurane Source) Market is growing at a CAGR of 3% over the 7 years.
Who are the Companies in the Sevoflurane (Sevoflurane Source) Market?
Abbott(AbbVie), Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui, Lunan,
What region does this Sevoflurane (Sevoflurane Source) Market report cover?
North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What is the significant Type of the Sevoflurane (Sevoflurane Source) Market?
Original Drugs, Generic Drugs
What is the major Application of the Sevoflurane (Sevoflurane Source) Market?
For Human, For Animal
Who are the Companies in the Sevoflurane (Sevoflurane Source) Market?
The Sevoflurane (Sevoflurane Source) Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise Application Outlook Types for multiple Application Outlooks. The three dependencies for the status of major Companies in the market are company profile, profitable gross margin, and the prices they charge. The main players are Abbott(AbbVie), Baxter, Maruishi Pharmaceutical, Jiangsu Hengrui, Lunan
Recent Development
Abbott Files NDA For Sevorane Anesthetic
Abbott Laboratories has filed a New Drug Application in the USA for its new inhalation anesthetic Sevorane (sevoflurane), seeking approval to market the drug for the induction and maintenance of general anesthesia in adult and pediatric patients for both inpatient and outpatient surgery.
What Are The Major Application, And Type Of The Sevoflurane (Sevoflurane Source) Market?
By Type, it is segmented into
- Original Drugs
- Generic Drugs
By Application, it is segmented into
Sevoflurane (Sevoflurane Source) Market Regional Analysis
The report provides a detailed analysis of the market for sevoflurane (Sevoflurane Source), including its growth and other aspects, in significant nations (regions), such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil, and Saudi Arabia. Additionally, it sheds insight on the development of significant regional Sevoflurane (Sevoflurane Source) markets, including those in North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
- North
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
- INTRODUCTION
- MARKET DEFINITION
- MARKET DYNAMICS
- MARKET SEGMENTATION
- REPORT TIMELINES
- KEY STAKEHOLDERS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT MATTER EXPERT ADVICE
- QUALITY CHECK
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- EXECUTIVE SUMMARY
- INTRODUCTION
- GLOBAL SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, BY TYPES
- GLOBAL SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, BY APPLICATIONS
- MARKET DYNAMICS
- DRIVERS
- INCREASING DEMAND FOR SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, RESTRAINTS
- STRINGENT ENVIRONMENTAL REGULATIONS
- HIGH COST ON MATERIALS
- OPPORTUNITIES
- SEVOFLURANE (SEVOFLURANE SOURCE) MARKET GROWTH
- APPLICATION OF SEVOFLURANE (SEVOFLURANE SOURCE) MARKET
- IMPACT OF COVID 19
- GLOBAL SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, BY TYPES
- INTRODUCTION
- ORIGINAL DRUGS
- GENERIC DRUGS
- OTHERS
- GLOBAL SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, BY APPLICATION
- INTRODUCTION
- FOR HUMAN
- FOR ANIMAL
- GLOBAL SEVOFLURANE (SEVOFLURANE SOURCE) MARKET, BY REGION
- NORTH AMERICA
- EUROPE
- GERMANY
- FRANCE
- UK
- ITALY
- RUSSIA
- REST OF EUROPE
- APAC
- CHINA
- SOUTH KOREA
- JAPAN
- INDIA
- AUSTRALIA
- ASEAN
- REST OF APAC
- MIDDLE EAST & AFRICA
- SAUDI ARABIA
- UAE
- SOUTH AFRICA
- TURKEY
- REST OF MEA
- SOUTH AMERICA
- BRAZIL
- REST OF MEA
- ARGENTINA
- REST OF SOUTH AMERICA
- COMPETITIVE LANDSCAPE
- MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
- AND AGREEMENTS
- MARKET SHARE /RANKING ANALYSIS
- STRATEGIES ADOPTED BY LEADING PLAYERS
- COMPANY PROFILES
- BUSINESS OVERVIEW
- COMPANY SNAPSHOT
- PRODUCT BENCHMARKING
- STRATEGIC INITIATIVES
- ABBOTT(ABBVIE)
- BAXTER
- MARUISHI PHARMACEUTICAL
- JIANGSU HENGRUI
- LUNAN
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
